Page last updated: 2024-10-23

azathioprine and Bradycardia

azathioprine has been researched along with Bradycardia in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fernandez, F1
Leandri, J1
de Mendonça, M1
Schwartz, K1
Halpern, B1

Other Studies

1 other study available for azathioprine and Bradycardia

ArticleYear
[Early electrocardiographic signs of rejection crises in experimental cardiac homotransplantation].
    Archives des maladies du coeur et des vaisseaux, 1972, Volume: 65, Issue:2

    Topics: Animals; Antilymphocyte Serum; Anura; Arrhythmia, Sinus; Azathioprine; Bradycardia; Cardiac Complexe

1972